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An accurate identification and characterization of pathogens is crucial in disease management. The appropriateness and 
effectiveness of the microbial diagnosis method influence the choice of the antimicrobial agent to be used in the treatment 
of infection. Traditionally, bacterial diagnosis is based on conventional and culturing-dependent approaches, such as 
culture and counting methods, generally coupled to morphological and physiological characterization. Currently, rapid 
technological advances in bacterial identification methods are occurring providing a bewildering wide range of techniques 
to detect, identify and differentiate bacteria. Molecular methods, such as ELISA and PCR, had introduced great 
improvements in bacterial identification as they contributed to speed up the analysis and the reduction of handling. 
However, it has been demonstrated that heterogeneous microbial communities are the main cause of several human 
infections. This genetic and phenotypic heterogeneity is crucial to microorganisms achieving adaptation to human host, 
and it might reflect distinct pathogenicity potential. The aforementioned molecular methods and new emergent methods, 
such as MALDI-TOF MS, have still limitations in full identification and differentiation of microbial heterogeneity. 
Therefore, a new generation of diagnosis methods able to detect and characterize microbial heterogeneity should be 
developed. Microbial infections are like dynamic systems and it is essential that diagnosis methods and technologies 
rapidly evolve to detect and measure changes occurring at individual and population level. This new kind of methods will 
allow a relevant shift about infection development understanding, as well about microbial mechanisms of resistance to 
antibiotics and human defences and persistence ability in human host that culminate in better medical decisions about 
antimicrobial therapy. 
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1. Introduction  
Microbial infections are a common cause or a recurrent complication of a panoply of diseases causing millions of 
deaths and demanding increased medical and social resources. A timely diagnosis is the most effective approach to 
prevent or control microbial infections or diseases. To perform a successful diagnosis and, consequently, to achieve an 
effective therapy, it is required an accurate and fast identification and characterization of the infecting pathogens, such 
as bacteria, fungi, viruses and parasites.  
 Apart from the food industry, the clinical diagnosis is the most interested field in microbial detection and 
identification since the implications of failing or delay in pathogen identification might be fatal to patients [1]. 
Therefore, methods for detection, identification and characterization are crucial for suitable antimicrobial therapy 
design. According pathogen identification and its biological traits, it is chosen the best antimicrobial approach to control 
or eradicate the microbial infection or disease. In addition, accurate identification is not only an issue of effective 
antimicrobial therapy but it also accounts for understanding the infection or disease development. Rapid pathogen 
detection, identification and characterization are, thus, the gold standard for diagnosis. 
 Over the years automated methods for microbial identification and characterization were continuously demanded 
attempting to respond to the clinical needs of fast and reliable diagnosis, as in cases of septicaemia or neonatal 
infections [2]. Automated tests have allowed increasing the number of clinical analysis and the accurate detection of 
several distinct microbial species at the same time. This more fast and accurate microbial profiling has significantly 
reduced patient mortality and morbidity rates.   
 In the context of microbial diagnosis, bacterial identification and characterization represents the largest interest of 
routine diagnosis, therefore this paper will focus essentially on bacterial diagnosis-identification methods. This paper 
will review the tools, technologies and methods currently available and applied in clinical field to perform bacterial 
diagnosis, and discuss technical procedures, advantages and drawbacks.  
2. Microbial heterogeneity 
Over the years, Koch’s postulate, which states that a disease is caused by a single causative agent, was on the basis of 
microbial diagnosis-identification methods development [3]. However, a growing body of evidences has demonstrated 
that several human infections or diseases are caused by complex and mixed microbial communities [4]. Besides this 
polymicrobial nature of infections, the complex microbial communities might encompass a wide phenotypic 
heterogeneity fundamental to microorganism survival and adaptation to human host. For instance, oxygen-limited or 
anaerobic environments in cystic fibrosis (CF) lungs force Pseudomonas aeruginosa to trigger mechanisms of 
adaptation. Bacteria in CF lungs undergo genetic, morphological and physiological changes to survive for long periods 
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of time under the challenging selective pressure imposed by the typical CF growth conditions, the immune system 
action and antibiotic treatments [5]. Clonal diversification of P. aeruginosa after infection establishment differs 
remarkably from the early stages of infection in CF lungs, being P. aeruginosa conversion from non-mucoid to mucoid 
phenotype the hallmark of airway CF [6]. Mucoid colony morphology results from alginate overproduction, absence of 
flagellin and pilin and expression of other virulence factors. Within mucoid form, P. aeruginosa is more difficult to 
eradicate because their augmented resistant to antibiotics, as well as to action of host immune defences [6-8]. This 
resistance and protection is mainly due to alginate production that for this reason is considered a significant virulence 
factor [9, 10].  
 Bacteria use the generation of microbial heterogeneity in a population as alternative to gene regulation mechanism 
because the predetermined sensor-effect regulatory circuits, used to respond to external stimuli, are insufficient to face 
unpredictable stressors. Microbial heterogeneity might be caused from genetic changes arise from random, semirandom 
or programmed events, including deletion, duplication and acquisition of genetic material [11], increased the rates of 
spontaneous mutations [12, 13], random transcription, phage-related events, chromosomal duplications and gene 
amplification [14]. Moreover, microorganisms might create phenotypic variants through phenotypic switching that 
consists in reversible conversion of phenotypic states according environmental changes. This mechanism, recently 
reviewed by Sousa et. al. [13], provides a dynamic source of heterogeneity without the fitness costs of irreversible 
mutations. Stress-inducible mechanisms as phenotypic switching can greatly accelerate the adaptive evolution of 
microorganisms, which is of serious concern in the scope of microbial diagnosis and therapy design. In contrast to DNA 
replication or transcription, a general stress-inducible mechanism was not noticed until now; only similarities and 
differences among a series of this kind of mechanisms are been reported. Therefore, there are not identified specific 
molecules that can be target for antimicrobials action in order to block these stress-inducible mechanisms. So far, there 
are just some probable active components since the mechanisms of phenotypic switching activation are highly 
dependent of environment stresses.  
 All the above mentioned findings have challenged the suitability of the actual microbial diagnosis. Microbial 
heterogeneity, namely intra-strain variability, has great impact in pathogen diagnosis as it might disturb the medical 
decision about the antimicrobial agent and respective dosage to administrate to patient. The ability of the method in 
providing accurate information about microorganism is crucial to design effective treatment strategies. The current issue 
on microbial diagnosis-identification is the ability of the methods generating not just taxonomic results, but also 
characteristic features about the microorganisms isolated from patients. A conceptual advance in the scope of microbial 
diagnosis is required considering the actual knowledge about microbial adaptation, evolution and infection 
development. 
 In the following sections, it will be reviewed the current technologies regarding microbial identification and 
characterization and the methods available and applied in clinical field. Insights into their technical procedures, 
advantages and drawbacks will be also provided. Special focus will be given to the ability of those methods to detect 
microbial heterogeneity. 
3. Microbial diagnosis methods  
Classically, microbial identification is based on microscopy of specimens and culturing on solid media [15]. Over the 
last decades, rapid advances in microbial identification methods have occurred providing a bewildering wide range of 
techniques to detect, identify and differentiate microorganisms.  
 An ideal diagnostic method must be sensitive, specific, rapid, easy to perform (not labour intensive), and the 
resulting data must also be easily to interpret, widely available, cost effective and high-throughput. Additionally, it 
should be taken into account the incidence of the microbial infection, how contagious is the pathogenic agent and the 
health consequences for the patient and community. Obviously, there is not an optimal microbial diagnosis method. The 
selection of an adequate identification method must be supported by criteria such as sensitivity and specificity of 
analysis and time duration [16]. The choice of a microbial diagnosis method or technology should as well consider its 
ability to explore cellular differences beyond identification of conserved domains or characteristics shared by species. 
In fact, microbial diagnosis must include biological key factors such as susceptibility profiles and virulence factors 
expression. These biological characteristics are not only important for antimicrobial therapy design but also for 
monitoring and surveillance of routes of hospital and community infections [17]. 
 Researchers are continuously searching for new tools that are fast, accurate, and ultrasensitive. It has been witnessed 
an increase research activity in the development of techniques for detecting and identifying pathogenic microorganisms 
[18]. The fast pace at which identification methods are being developed prompts the overview of the most predominant 
methodologies applied in clinical diagnosis of pathogens and their scientific principles emphasising bacterial 
identification techniques.  
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3.1. Conventional or culture-based methods 
Conventional or culture-based diagnosis methods are based on the ability to growth microorganisms in vitro, i.e., in 
artificial conditions. Culture and colony counting, Gram staining and morphological characterization are some examples 
of these methods and all of these rely on specific and biochemical identification [19, 20]. Generally, clinical samples are 
plated on a solid selective enrichment medium, or differential agar plates, to detect or isolate specific microbial species. 
To simply enumerate and identify the microbial population present in the sample, a general solid medium must be used. 
These methods are very sensitive, easily adaptable, quite inexpensive and they can return both qualitative and 
quantitative data about the bacterial population present in the clinical samples [20-22]. However, typical clinical 
samples are mixed cultures of microorganisms that can include several pathogenic species but also normal flora. In 
most cases, isolation procedures should be performed in order to obtain pure cultures. Therefore, the culture-based 
methods become labour-intensive and time-consuming because they have to include besides the usual culture medium 
preparation and inoculation of agar plates steps, a broad range of bacterial growth steps for species and/or strain 
isolation. Results are only obtained within 1–3 days and up to 7–10 days for confirmation [2, 19]. After the microbial 
isolation steps, pathogen characterization through phenotypic and susceptibility tests have to be performed [2, 22].  
 In the past, microbiologists and clinicians were trained to consider microorganisms as culturable. Therefore, the 
absent of microbial growth would meant absence of microorganisms in samples. However, infections may encompass 
within microbial population senescent or dormant cells that are viable but not able to growth in vitro conditions.  
 The detection of unculturable cells is particular relevant in biofilm-associated infections. Biofilms are microbial 
communities encased in self-produced matrix composed of exopolysaccharides, proteins and DNA. These sessile 
microbial forms provide an impressive source of genetic and phenotypic diversity [23, 24]. Moreover, biofilm 
populations might encompass increased number of dormant cells or persisters [25-27]. Persister cells are antibiotic-
tolerant, not resistant cells, due to their non-growing state. They represent a small fraction (less than 1 %) of the 
population, being its detection very difficult and rare. As the majority of the antibiotics is only effective against growing 
cells, persisters are often out of the antibiotics action and thus a major obstacle of clinical diagnosis and infections 
treatment. After an antimicrobial action either of antibiotics or immune defences, persisters are able to restore the 
original population with similar susceptibility [28, 29].  
 In some cases, culture-based methods have additional limitations resulting from the great difficulties in growing 
specific pathogens in artificial media due to, for instance, particular growth and/or storage and transportation conditions 
of the clinical samples. 
 Concerning staining methods, Gram staining is the most applied as it can provides results within minutes. However, 
complete microbial identification usually takes 1 or more days because staining methods may be difficult to interpret or 
be inconclusive, requiring often specialized staff [30]. 
 Despite the technological advances, culture-based methods are fundamental to clinical diagnosis and its usage still 
remains in clinical practice because, conversely to other methods, they can detect acute infections in early stages with 
selectivity and sensitivity [1, 17, 19, 22]. 
 As conventional methods require several days to give results, as they depend on bacteria ablity to multiply and form 
visible colonies, the accuracy and reliability of these methods are strongly dependent on skilled taxonomical expertise 
[16]. Therefore, any modification on these methods reducing the time of analysis is welcome.  
 Currently, there are available some automated identification systems, such as the blood culture systems BacTec 
(Becton Dickinson, Franklin Lakes, NJ, USA), BacT/Alert (bioMérieux, Marcy l’Etoile, France) and the systems 
VITEK (bioMérieux), PHOENIX (Becton Dickinson), or Microscan WalkAway (Siemens Healthcare Diagnostics, 
Munich, Germany), that give reliable results in shorter periods of time and allow, in addition, the antimicrobial 
susceptibility testing. However, the analysis must be performed from pure cultures [17]. 
3.1.1. Colony morphology characterization 
Identification of a microorganism may follow two analyses: 1) phenotypic characterization, i.e. the study of the 
observable traits resulted from gene expression, or 2) genotypic characterization, i.e. the study of the traits encoded 
within its genome [31]. Colony morphology relies on the characterization of the phenotypic traits exhibited not by an 
individual microorganism but by a group of microorganisms-colonies. This technique consists in plating clinical 
samples on solid growth medium and observed to the naked eye the colonies formed by those bacteria. Analysis of 
clinical pure isolated cultures from agar plates is routinely performed with simple protocols [22].  
 Despite the fact that several authors described it as old-fashioned [2, 17], colony morphology characterization is 
commonly used to complement conventional microbial identification (e.g. staining and biochemical tests) [32-34]. The 
simple procedure, no specific technical skills to perform and analyse colony morphology formed by bacteria, as well as 
its low cost, are definitely its main advantages over the actual advanced techniques. Its major drawback is the long 
interval of time to obtain results that take normally 1-3 days [33].  
 With exception of colony morphology characterization, microbial heterogeneity is usually masked in some 
conventional methods, such as biochemical tests, because they rely on an average of millions of cells of a clinical 
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sample, Through colony morphology characterization, individual microbial diversity, both derived from genetic 
changes or reversible changes as those occurred in phenotypic switching, can be indirectly evaluated [35]. 
 Colony morphology characterization has been used for different purposes as an indicator of biological changes in 
bacteria caused by mutations, plasmid insertions, environmental effects, antimicrobial agents action and virulence 
potential. Applied to clinical diagnosis, colony morphology characterization has undoubtedly advanced the knowledge 
about microbial diversity, adaptation and evolution. For instance, as abovementioned P. aeruginosa properties change 
according to CF lung disease development. The clonal diversification of P. aeruginosa in CF lungs was evident when 
plating bacteria on agar plates and observed their different colony appearance among non- and mucoid phenotypes. 
Another interesting colony variant frequently exhibited by Staphylococcus aureus isolated from chronic bacterial 
infections, such as osteomyelitis and device-related infections, is the small colony variant (SCV). Its designation comes 
from their small-colony size, typically 10 times smaller than the usual S. aureus colonies, after 24-48 h of growth on 
agar media [36, 37]. SCV are normally hyperpiliated, hyperadherent, auxotrophic, excellent biofilm formers and exhibit 
autoaggregative behaviour [36]. In addition, SCV also show augment resistance to several classes of antibiotics [38, 
39], reason by that they persist more efficiently in the host. SCV have been observed for other bacterial species that not 
only S. aureus [40-43]. 
 Altered colony appearance was demonstrated for several other bacteria species such as Burkholderia pseudomallei 
[44], Streptococcus pneumonia [42], Enterococcus faecalis [45] and Haemophilus influenza [46]. Any modification in 
colony morphology, such as colour, opacity, size and texture, may be a sign of altered expression of one or more 
bacterial traits. The correlation between bacterial features, such as antimicrobial resistance, virulence factors expression 
and persistence ability, and colony morphologies is just about unknown, however extremely important. The current 
knowledge about these relationships is scarce due to the existence of several barriers of the colony morphology 
characterization, in addition to those inherent of being a culturing dependent method. In fact, the lack of standard 
experimental guidelines, universal morphological criteria, unequivocal concepts and terms to perform colony 
morphology evaluations are the main handicaps of this method. Colony morphology descriptions have been performed 
without consensus of experimental parameters, such as time of colony growth, solid media usage and colony density per 
plate. Moreover, the colony descriptions have been performed according authors assumptions using their own criteria, 
vocabulary and concepts about morphological traits. Therefore, the knowledge gained about bacterial diversity is 
somewhat inconsistent and unstructured.  
 The methods of bacterial isolation and identification remain almost unchanged since their first utilization. Currently, 
it is demanded high-throughput analysis and automated systems that can return rapid and reliable results. The authors 
consider colony morphology characterization with great potential in clinical diagnosis and crucial improvements must 
be performed. Therefore, some efforts have been performed to become colony morphology characterization an 
advanced method [47, 48]. REF JMM 
3.2. Molecular methods 
Molecular methods, such as immunological and nucleic acid-based techniques, seriously improved microbial diagnosis. 
Compared to traditional culture-based methods, molecular techniques have some advantage because they use more 
stable genotypic characteristics than reversible phenotypic characteristics. Molecular methods are more adequate for 
routine analysis since they are generally faster, more specific, sensitive and accurate. Moreover, these methods can be 
performed and results interpreted by staff with no taxonomical expertise [17, 19]. Results can be obtained in a expedite 
way because molecular methods are based on the detection of molecules that can be extracted directly from bacteria 
without the need of culturing This means that the microbial community can be elucidated through its molecular 
composition [3, 49].  
3.2.1. Immunological Techniques 
Almost 30 years ago, immunological (or serological or antibody-based) techniques arose originally to detect viruses.  
The development of immunoassays introduced great improvements in microbial diagnosis because they were the first 
technique able to perform rapid identification and characterization without culturing steps [17]. 
 Immunological techniques are based on the binding between diagnostic antibodies and specific antigenic 
determinants of the target bacteria. The enzyme-linked immunosorbent assay (ELISA) is the most common used 
technique. Despite the different types of ELISA actually available, such as immunofluorescence assays, latex 
agglutination assays, line immunoassays or lateral-flow immunoassays, all involve an enzyme-mediated colour change 
reaction to detect and often also to quantify antibody binding as a measure of pathogen presence [1, 18, 21]. ELISA 
techniques have improved the clinical diagnosis due to their high-throughput capacity, speed, relatively low-cost and 
simple nature, as well as because the possibility to quantify the target pathogen [17, 19].  
 Another immunological approach is the serological assays. Since the human body produces specific antibodies in 
response to microbial infection, it is possible to use those antibodies to detect an acute or past infection. Antigen 
microarrays introduced great improvements in diagnosis enabling testing several pathogens at the same time. However, 
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serological assays are usually ineffective due to its long duration before seroconversion. Some automated advances 
were already performed to short the assay duration [17, 50]. 
 Similar to all techniques, immunology-based methods have also some limitations. Lack of selectivity and sensitivity 
are their major limitations due to the difficulty to generate selective antibodies and the requirement of large amounts of 
the respective antigen to quantify bacteria. The development of antibodies with the required degree of specificity is 
difficulty for complex organisms as bacteria. Polyclonal antibodies were introduced to overcome this limitation and 
they are used successfully in bacteria detection because of the recognition of multiple epitopes. However, not always 
they exhibit the sufficient specificity to detect bacteria. Such limitation can be overcome through monoclonal or 
recombinant antibodies, but often epitopes are ubiquitously shared within bacterial species. Therefore, antibody-based 
assays are relatively unsophisticated for the detection of bacteria [16-18]. 
3.2.2. Nucleic acid-based techniques 
The use of nucleic acid-based techniques for the detection and identification of bacteria was initiated when polymerase 
chain reaction (PCR) was developed in the early 1980s. Through the advent of PCR, it was possible to amplify DNA 
sequences and make their presence into a detectable signal. The “boom” of information availability started just with the 
access to the pathogen gene sequence. As result, public databases like GenBank 
(http://www.ncbi.nlm.nih.gov/Genbank/) started growing [50].  
 Nucleic acid-based techniques encompass DNA- and RNA-based technologies. DNA-based technologies include 
PCR, and its variations, and DNA microarrays. RNA-based technologies include reverse transcriptase PCR (RT-PCR) 
and transcription mediated amplification (TMA) [49]. 
 The main characteristic of all nucleic acid-based techniques is the selection of genetic sequences through which it is 
possible to identify pathogens. Generally, the pathogen identification is performed, choosing ubiquitously conserved 
genes, called housekeeping genes, or through screening of random parts of the its genome [16]. Targeting genes 
encoding resistance and/or virulence factors may be useful to obtain information about microbial pathogenicity [17]. 
 PCR techniques have the ability to produce millions of copies of a specific portion of DNA sequence, that may be a 
gene or gene clusters, with high fidelity in 3 to 4 h. Through the use of nucleotide sequences from 16S ribosomal RNA 
genes, it is now possible to identify or, at least, to infer about the bacterial species [3, 21, 22, 51]. For the detection of 
bacteria, PCR uses primers that are 20-30 nucleotides sequences homologous to the ends of genomic DNA region to be 
amplified. The conventional PCR procedure consists in a thermocyclic process of repetitive cycles of DNA 
denaturation, primer annealing and extension through a termostable DNA polymerase. The detection of the amplified 
sequence is performed through agarose gel electrophoresis using fragment length as indicator for identification [1, 17]. 
If particular pathogen identification is intended, a unique DNA sequence is determined and specific primers are 
designed enabling the determination of pathogen presence or absence. PCR-based methods are very sensitive being the 
results obtained within few hours, 5 to 24 h, with increased identification accuracy [1, 3, 21, 49].  
 Despite PCR had provided great improvements in microbial diagnosis, the use of species-specific sequences to detect 
and identify pathogens requires the prediction of the species presence in the clinical samples. This limitation is similar 
to that of culture-based methods and equivalent to the need of selective culture media to determine species 
identification. In addition, there is a limited number of PCR assays that can be perform per clinical sample and 
infections or diseases are not monocultures being frequently caused by species-species interactions or even strain-strain 
interactions [3]. In attempt to overcome these limitations, a multiparameter approach, the multiplex PCR that allows 
multispecies analysis, was developed. However, similar to other PCR approaches, multiplex PCR need some prediction 
of the bacterial species present in the clinical samples [1, 3, 17].  
 Measurements based on DNA species-specific sequences do not allow detecting heterogeneity on bacterial 
population and determining the metabolic state of cells. Nucleic acid-based technologies equally detect metabolic 
active, senescent and dead cells because they just detect intact DNA. From the point of view of infection, the 
discrimination of the metabolic state of cells is fundamental [17]. As abovementioned, the presence of persisters cells is 
one of the main causes of chronic infections [25] as  they are able to grow and restore the microbial population even 
after aggressive antimicrobial therapies. The diagnosis of persisters is crucial to design effective approaches to eradicate 
all microbial population and to avoid repeated exacerbations, antibiotic resistance episodes and, consequently, the 
establishment of chronic infections.  
 In addition, the presence of extracellular DNA might influence the DNA-based signals detected. In CF lungs, for 
instance, significant amounts of extracellular DNA released by bacterial cells destroyed by immune defences have been 
detected. Therefore, DNA-based signals obtained during diagnosis will be influenced by the presence of extracellular 
DNA that might lead to misidentification. This measurement artefact can be minimized adding propidium monoazide 
(PM) prior to nucleic acids extraction. PM does not enter in cells that have structural integrity, connecting just with 
extracellular DNA or with DNA of dead cells. PM intercalates into double-stranded nucleic acids with chemical cross-
links formed with bright light exposure. Therefore, the DNA linked with PM is unable to be used as template for PCR 
reactions [52]. The PM application is crucial in airway sputum samples. 
 Taxonomic identification, as abovementioned, is not sufficient to design an efficient antimicrobial therapy. More 
biological details about bacteria must be provided including resistance profiles and virulence factor expression. PCR 
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approaches are able to provide such information, however PCR must be performed targeting resistance and virulence 
coding factors genes to determine biological profiles. 
 In summary, pathogen identification in clinical context remains a challenging task for all assays and technologies. 
Effective identification requires methods of analysis that have to meet a number of challenging criteria, being time to 
obtain results and sensitivity the most important (Table 2). Clinical diagnosis needs more rapid and sensitive methods 
able to provide the most complete results possible. 
 
Table 1 Characteristics of conventional (culture-based), immunological and nucleic acid based-assays. Adapted from [16, 19]. 
Method Assay duration (hours) 
Detection limit 
(cfu/mL or g) Time before result Specificity 
Plating technique > 72 1 1-3 days Good 
Immunological technique 1-3 104 1-2 hours Moderate/good 
Nucleic acid-based technique 1-3 103 6-12 hours Excellent 
3.3. New emergent methods: MALDI-TOF MS  
Few developments in microbial diagnosis have had so impact in identification of pathogens as matrix-assisted laser 
desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) [31, 53]. Indeed, among the new emergent 
methods, MALDI-TOF MS is the most used to identify microorganisms and has already replaced conventional methods 
in some laboratories [2].  
 MALDI-TOF MS approaches are able to perform species identification and even strain differentiation based on 
molecular signatures. It is based on the ionization of cocrystallized sample material by short laser pulses. The ions are 
accelerated and their time of flight is measured in a vacuum flight tube [15]. MALDI-TOF MS has seriously improved 
clinical diagnosis not just of bacterial pathogens, as well as in detection of tumors, rheumatoid arthritis, Alzheimer’s 
disease, and allergies through the identification of specific biochemical markers [54]. The successful implementation of 
this technique in the routine of laboratories is due to its fast, easy and high-throughput characteristics. Moreover, it 
generates simple and easily interpretable spectra.  
 To identify bacteria by MALDI-TOF MS, samples are dissolved in a matrix solution and placed on the steel surface 
of the target plate to dry. After matrix and sample cocrystallization on the target plate, the mixture is then transported to 
the measuring chamber [15]. Once a sufficient vacuum has been created, the individual samples are exposed to short 
laser pulses. Bacteria and matrix are vaporized by the laser energy, leading to the ionization of the analytes, typically 
(ribosomal) proteins. The ions are vaporized in an electromagnetic field, created by a potential of about 20 kV, before 
they enter the flight tube [15, 55]. The time of flight (TOF) of the proteins to reach the detector at the end of the flight 
tube is precisely measured. The degree of ionization and the mass of the proteins determine their individual TOF. Based 
on this TOF information, a characteristic spectrum is recorded constituting a specific sample fingerprint, which is 
unique for a given species. Increased m/z (mass and ion charge ratio) corresponds to lower speed and longer time need 
to reach the detector [55, 56]. 
 It was demonstrated that MALDI-TOF MS and conventional identification methods are both highly accurate for the 
identification and differentiation of isolated bacteria and yeast [53, 57, 58].  Minor discrepancies between biochemical, 
molecular, and MALDI-TOF MS-based identification and differentiation results have been observed [59]. Differences 
are seen mainly because MALDI-TOF MS pathogen identification is based on the analysis of ribosomal protein spectra. 
Species that do not differ sufficiently in their ribosomal protein sequences, such as E. coli or S. pneumonia, are still hard 
to be differentiated by MALDI-TOF MS [32, 60]. 
 MALDI-TOF MS has been used as new strategy for directly bacterial pathogen identification in clinical samples such 
as blood [61] and urine [62]. The fast and reliable results obtained coupled with simple procedure, without a cultural 
enrichment step, have made this method popular in clinical diagnosis context [2, 59, 63]. Furthermore, it is a high-
throughput technique that returns increased amount of detailed data about microbial community composition, including 
non- and culturable bacteria at the same time [2, 3].  However, some clinical sample material is most often rich in host 
proteins and normal flora, which might occur overlapping of mass spectra [15]. So, in these cases, additional protocol 
steps are required to accurately perform MALDI-TOF MS analysis. This approach has been as well applied to 
differentiate genotypes detecting the presence of genetic elements coding the expression of antibiotic resistance and 
virulence factors. Several authors have reported the ability of MALDI-TOF MS to discriminate isolates in methicillin-
resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA) [64-66]. Despite the 
progressive advances demonstrated in microbial diagnosis field, the Food and Drug Administration, in the United 
States, does still not approved the function of MALDI-MS systems for pathogen identification [2].  
 Similar with epidemiological typing of bacterial isolates, i.e., differentiation of strains through specific mass peaks 
detection, typing of bacterial colony morphology variants using MALDI-TOF MS had received the interest from the 
authors. Authors intended to test other application of MALDI-TOF MS in microbial diagnosis field. Recent work 
revealed that MALDI-TOF MS exhibited distinct results comparing with colony morphology profiling [67].  
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 MALDI-TOF MS, similar to other techniques, it has still limited sensitivity since it required 104-105 cells per assay 
that is rarely found in clinical samples, with exception of some urinary samples [22]. It has also as well limited ability to 
detect resistant bacteria due to the most of the genes encoding antibiotic resistance are mobile genetic elements acquired 
by horizontal gene transfer and are not necessarily linked to systemic taxonomic relationships [15, 31]. Unculturable 
microorganisms are also a limitation of MALDI-TOF MS. Because those microorganisms are typically less than 10% of 
the population, mass spectra obtained are prone to be lost in background noise [31]. Costs are also an important factor 
when considering integrating this technique into a laboratory. The initial investments and maintenance costs are 
extremely high in contrast to low overall operating costs. High throughput sample analysis and the low amount of 
consumables required, dependent of MALDI-TOF MS approach applied, makes this method competitive [2, 15]. 
Although just one instrument usually is needed to process all number of samples per day of a hospital or clinical 
laboratory, technical problems with it might stop samples analysis and might have great impact on hospital and clinical 
routine [2]. 
4. Future trends 
In addition to the technical development that actual methodologies offer, a conceptual advance in microbial diagnosis 
reflecting the information available about microbial adaptation and evolution is essential. Methods or technologies able 
to detect and profile microbial communities certainly will have impact in microbial diagnosis and, consequently, in 
antimicrobial therapy. Through those methods, it will be possible to determine the population heterogeneity and target-
specific antimicrobial therapies, avoiding by this way antibiotic resistance episodes and acute and repeated 
exacerbations of infections [14]. As previously mentioned, microbial heterogeneity is usually masked in conventional 
methods with exception of colony morphology characterization. Despite the great potential of colony morphology 
characterization, only few improvements have been noticed in this method. Therefore, the authors of this present work 
already performed some improvements in colony morphology characterization technique in order to standardize and 
become a semi-automated technique (data unpublished).  
 Other techniques and methods are also available, able to detect heterogeneity at single-cell level. In fact, some 
microscopy methods, such as light microscopy (bright or dark field, fluorescence and phase control) and electronic 
microscopy (SEM, TEM) have also potential to detect microbial heterogeneity, however they are less frequent used in 
clinical laboratories and more applied in research centres [2]. However, promising advances were already performed in 
this area.  
 Fluorescent in situ hybridization (FISH) have been revealed an attractive and promising tool for rapid and reliable 
detection and identification of bacteria. FISH assays combine microscopic and molecular methods being so rapid and 
ease-of-use, as typical in staining methods, and specific like molecular methods. Assays consist in direct hybridization 
using labelled oligonucleotides probes (15 to 25 nucleotides in length) covalently labelled at 5’ end with fluorescent 
labels that are species-specific [17, 68, 69]. Further hybridization, stained cells are detected using epifluorescent or 
confocal laser microscopy. As a DNA-based method, the use of species-specific DNA sequences has the advantage to 
detect and identify unculturable and slow-growing bacteria that other methods cannot perform it. However, it is need 
isolation and pre-culture in liquid and solid media to produce a significant amount of target cells to obtain a detectable 
signal, which makes this method lacked of sensitivity. This limitation can be overcome targeting rRNA that exists in 
higher amount in bacterial cell and facilitates the description of the complex microbial communities associated to 
infections. In addition, there are a limit number of probes that can be used in one experiment and background 
fluorescence might be a problem in some clinical samples. Moreover, the use alone of FISH does not provide 
information about cellular metabolic state [17, 68, 69].  
 In recent years, the application of “omics” technologies, including genomics, transcriptomics, proteomics and 
metabolomics, for discriminate the microbial diversity of the infection community has definitely gave rise to 
improvements in the scope of microbial diagnosis [70]. They have allowed the determination of gene expression, as 
well as the respective timing, stimuli-dependent and molecular coding expression. However, the proprieties of a 
microbial community result from interactions between multi-phenotypes and/or interactions between differential 
biochemical niches, which can be metabolic, predatory, competitive or cooperative. The whole interactions that happen 
within the community define its interaction with the human host environment [71]. The current methods of cultivation, 
biochemical and molecular characterization allow to associate bacterial species and their activities but not understand 
their network. “Omic” technology alone is not truly useful to determine and characterize complex microbial 
communities.  
 The microbial diagnosis has already advanced to metagenomic where it is possible to catalogue the complex mixtures 
of genomic components of the bacteria species analyzing the microbial DNA of the community directly from natural 
samples. The early environmental gene sequencing of the clones allows obtaining a natural profile of the diversity in the 
samples. The advantage of this approach is the absence of clones cultivation and PCR steps, avoiding by this way 
missing the detection of unculturable microorganisms, as well as to reduce the potential of bias introduced by 
amplification [71, 72]. Metagenomics is truly important, for instance, to discriminate differences between the normal 
flora and unhealthy microbial composition in order to link specific microbial populations with environmental alterations 
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or processes. In addition, it also allows determining the effect of antimicrobial agents in the treatment of microbial 
infections and diseases. Such information is fundamental to implement in real-time effective and custom antimicrobial 
therapies to prevent or control microbial infections, as well as to assist microbial surveillance [22]. So far, metagenomic 
is not applied in clinical diagnosis routine. 
5. Conclusions 
The growth conditions in the human host impose to bacteria physiological changes that they undergo to adapt and 
survive. Current evidences have demonstrated that microorganisms are able to diversify expressing degrees of 
resistance and virulence at different times in order to persist in human body. Microbial adaptation is relevant to the 
infection or disease progression, thus it is need to be taken into account in microbial diagnosis. Over the last years, 
clinical laboratories have undergone important changes with the introduction of molecular and automated techniques. 
Today, the most applied diagnosis methods in clinical field are those based on culture and counting methods and PCR, 
mainly due to their selectivity and reliability. Although culture-based methods are more time-consuming and labour-
intensive than PCR, both provide conclusive and unambiguous information. However, the limitations of the current 
microbial diagnosis methods and technologies and the introduction of novel systems to deal with the unpredictable 
microbial heterogeneity must be recognized. Instruments equipped with automated systems, such as databases search 
functions, for pathogens identification and mainly for pathogens profiling, including antimicrobial resistance and 
virulence factors expression, are urgently needed.  
 Despite this paper only had focused on bacterial infections and diseases, microbial diagnosis is even more 
complicated. Clinical samples are composed not just by multi bacterial species but also by fungal and viruses. 
Therefore, microbial diagnosis-identification methods should be adequate to this polymicrobial nature. These advances 
will benefit not just microbial diagnosis, but also the elucidation of the mechanisms underlying infection development 
and bacterial adaptation to human host. These inputs will help the discovery of new therapeutic approaches to control or 
eradicate microbial-associated infections. 
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